ETR:SBS - Stratec Biomedical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€72.00 +0.40 (+0.56 %)
(As of 06/18/2018 04:20 AM ET)
Previous Close€71.60
Today's Range€71.30 - €72.10
52-Week Range€48.97 - €75.00
Volume1,251 shs
Average Volume6,253 shs
Market Capitalization$833.27 million
P/E RatioN/A
Dividend Yield1.10%
BetaN/A

About Stratec Biomedical (ETR:SBS)

Stratec Biomedical logoSTRATEC Biomedical AG designs and manufactures solutions for automated processes in the fields of in vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Consumables segment develops and sells scientific materials, such as nucleic acid purification; and designs and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC Biomedical AG also develops workflow software for networking several analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical Systems AG and changed its name to STRATEC Biomedical AG in April 2011. STRATEC Biomedical AG was founded in 1979 and is headquartered in Birkenfeld, Germany.

Receive SBS News and Ratings via Email

Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolETR:SBS
CUSIPN/A
Phone+49-7082-79160

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins18.89%
Return on Equity26.35%
Return on Assets15.03%

Miscellaneous

EmployeesN/A
Outstanding Shares11,910,000

Stratec Biomedical (ETR:SBS) Frequently Asked Questions

What is Stratec Biomedical's stock symbol?

Stratec Biomedical trades on the ETR under the ticker symbol "SBS."

What price target have analysts set for SBS?

6 brokers have issued twelve-month target prices for Stratec Biomedical's shares. Their forecasts range from €58.00 to €81.00. On average, they anticipate Stratec Biomedical's stock price to reach €66.23 in the next year. View Analyst Ratings for Stratec Biomedical.

Who are some of Stratec Biomedical's key competitors?

Who are Stratec Biomedical's key executives?

Stratec Biomedical's management team includes the folowing people:
  • Mr. Marcus Wolfinger, Chairman of Board of Management & CEO (Age 51)
  • Dr. Robert Siegle, Director of Fin.s & HR and Member of Board of Management (Age 51)
  • Dr. Claus Vielsack, Director of Product Devel. & Member of Board of Management (Age 51)
  • Mr. Hermann Leistner, Founder & Advisor (Age 72)
  • Sandra Eberle, Head of Investor Relations

Has Stratec Biomedical been receiving favorable news coverage?

Media stories about SBS stock have been trending somewhat positive on Monday, according to Accern. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Stratec Biomedical earned a news sentiment score of 0.05 on Accern's scale. They also gave news headlines about the company an impact score of 45.36 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

What is Stratec Biomedical's stock price today?

One share of SBS stock can currently be purchased for approximately €72.00.

How big of a company is Stratec Biomedical?

Stratec Biomedical has a market capitalization of $833.27 million.

How can I contact Stratec Biomedical?

Stratec Biomedical's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160.


MarketBeat Community Rating for Stratec Biomedical (SBS)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  100 (Vote Outperform)
Underperform Votes:  59 (Vote Underperform)
Total Votes:  159
MarketBeat's community ratings are surveys of what our community members think about Stratec Biomedical and other stocks. Vote "Outperform" if you believe SBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.